SIX •
Healthcare •
Drug Manufacturers - General •
Quote as of 07/24/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeSIX
Market Capitalization237,969 mln
Float1,859 mln
Earnings Date07/21/2026
EPS
5.65
Strong
P / E
22.45
Premium valuation
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.7
Likely reliable
1-Year Forecast
125
Fairly priced
Relative Strength
83
/ 100
Strongly outperforming
Business Description
Novartis AG is a Swiss-based global pharmaceutical company founded in 1996 and headquartered in Basel, with operations spanning research, manufacturing, and sales across international markets. The company develops and sells a broad range of medicines targeting serious conditions including heart failure, cancer, autoimmune diseases, and rare genetic disorders. Its portfolio includes well-established treatments such as Entresto for heart failure, Cosentyx for inflammatory conditions, Kisqali for certain cancers, and Zolgensma for spinal muscular atrophy, among many others. Novartis also holds a collaboration agreement with Alnylam Pharmaceuticals to develop and commercialize Leqvio, a therapy designed to lower harmful cholesterol levels.
